English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, July 27, 2020
Aptorum Group Becomes the First Nasdaq Listed Biopharmaceutical Company Admitted to Trading on Euronext Paris Stock Exchange Under the Ticker Symbol APM
Monday, March 30, 2020
知临集团与Covar医疗携手依托现有Smart-ACTTM平台和Acticule传染病平台研究至少3种2019冠状病毒肺炎(COVID-19)候选再利用药物(SACT-COV19)
知臨集團與Covar醫療攜手依託現有Smart-ACTTM平台和Acticule傳染病平台研究至少3種2019冠狀病毒肺炎(COVID-19)候選再利用藥物(SACT-COV19)
Aptorum Group Collaborates with Covar Pharmaceuticals to Investigate 3 Repurposed Drug Candidates (SACT-COV19) for Coronavirus Disease 2019 (COVID-19) under Existing Smart-ACT Platform and Acticule Infectious Disease Platform
知临集团将举行2020年第一季度投资者跟进电话会议以讨论最新进展和产品线进度
知臨集團將舉行2020年第一季度投資者跟進電話會議以討論最新進展和產品線進度
Aptorum Group Limited Corporate Update and To Hold Q1 2020 Investor Update Call To Discuss Recent Development and Pipeline Progress
Monday, February 24, 2020
知临集团开始商业化山药生物活性营养片剂并在香港签署销售分销协议
知臨集團開始商業化山藥生物活性營養片劑並在香港簽署銷售分銷協議
Aptorum Group Commences Commercialization of Dioscorea Opposita Bioactive Nutraceutical Tablets and Signed Sales Distribution Agreement in Hong Kong

Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6653 1210 | Tokyo: +81 3 6859 8575